Anixa Biosciences Inc
ANIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000715446
In the last 90 days, Anixa Biosciences Inc insiders filed 15 open-market purchases and 0 sales; 63 institutions reported holding it in 13F filings for Q2 2026, worth $15.0M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Anixa Biosciences Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 41 | 49 | +8 |
| Shares | 3.47M | 3.64M | +161.4K (+4.6%) |
| Value | $17.1M | $15.5M | −$1.64M (−9.6%) |
New holders (10)
Institutions that held Anixa Biosciences Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stifel Financial Corp | 30,000 | $127.5K | 0.00% |
| Qube Research & Technologies Ltd | 22,712 | $96.5K | 0.00% |
| Bridgeway Capital Management, LLC | 21,000 | $89.3K | 0.00% |
| CI Private Wealth, LLC | 20,000 | $85.0K | 0.00% |
| Nations Financial Group Inc, | 13,000 | $55.3K | 0.01% |
| International Assets Investment Management, LLC | 11,000 | $46.8K | 0.00% |
| Freedom Wealth Alliance, LLC | 5,453 | $23.2K | 0.03% |
| Advisory Services Network, LLC | 674 | $2.87K | 0.00% |
| Tower Research Capital LLC (TRC) | 203 | $1.00K | 0.00% |
| CWM, LLC | 250 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Anixa Biosciences Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Millennium Management LLC | 36,249 | $178.0K |
| BNP Paribas Arbitrage, SA | 97 | $477 |